Find information on thousands of medical conditions and prescription drugs.

Neurofibromatosis type 2

Neurofibromatosis Type II (or "MISME Syndrome", for "Multiple Inherited Schwannomas, Meningiomas, and Ependymomas") is an inherited disease. The main manifestation of the disease is the development of symmetric, non-malignant brain tumours in the region of the cranial nerve VIII, which is the auditory nerve that transmits sensory information from the inner ear to the brain. Most people with this condition also experience problems in their eyes. NF II is caused by mutations of a gene which probably influences the form and movement of cells. The principal treatments consist of neurosurgical removal of the tumors and surgical treatment of the eye lesions. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
Narcolepsy
Necrophobia
Necrotizing fasciitis
Neisseria meningitidis
Nemaline myopathy
Neonatal hemochromatosis
Neophobia
Nephophobia
Nephrogenic diabetes...
Nephrotic syndrome
Neuraminidase deficiency
Neurasthenia
Neuroacanthocytosis
Neuroblastoma
Neurofibrillary tangles
Neurofibroma
Neurofibromatosis
Neurofibromatosis type 2
Neuroleptic malignant...
Niemann-Pick Disease
Nijmegen Breakage Syndrome
Nocardiosis
Noma
Non-Hodgkin lymphoma
Noonan syndrome
Norrie disease
Nosophobia
Nyctophobia
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

There is no therapy for the underlying disorder of cell function caused by the genetic mutation.

Causes

Incidence, Mode of transmission, Epidemiology

NF II is an inheritable disorder with an autosomal dominant mode of transmission. Incidence of the disease is about 1 in 35,000. There is a broad clinical spectrum known, but all patients checked have been found to have the same mutation of a gene on chromosome 22. It is suspected that statistically, one half of cases are inherited, and one half are the result of new, de novo mutations.

Pathogenesis, Molecular Biology and pathophysiological relations

NF II is caused by a defect in the gene that normally gives rise to a product called "Merlin" or "Schwannomin", located on chromosome 22 band q11-13.1. This peptide is thought to have a tumor-suppressive function. The NF II gene is presumed to result in either a failure to synthesize Merlin, or the production of a defective peptide that lacks the normal tumor suppressive effect. The Schwannomin-peptide consists of 595 amino acids. Comparison of Schwannomin with other proteins shows similarities to proteins that connect the cytoskeleton to the cell membrane. Mutations in the Schwannomin-gene are thought to alter the movement and shape of affected cells with loss of contact inhibition.

Pathology

The so called acoustic neuroma of NF II is in fact a Schwannoma of the nervus vestibularis. The wrong term is used despite better knowledge in the whole scientific and medical literature. The vestibular Schwannomas grow slowly at the inner entrance of the internal auditory meatus (meatus acousticus internus). They derive from the nerve sheaths of the upper part of the nervus vestibularis in the region between the central and peripheral myelin (Obersteiner-Redlich-Zone) within the area of the porus acousticus, 1 cm from the brainstem.

Genotype-Phenotype-Correlation

Many patients with NF II were included in studies which were designed to compare disease type and progression with exact determination of the associated mutation. The goal of such comparisons of genotype and phenotype is to determine whether specific mutations cause respective combinations of symptoms. This would be extremely valuable for the prediction of disease progression and planning of therapy even at children age. The results of such studies are the following:

  • In most cases the mutation in the NF II gene causes shortened peptides.
  • There are no mutational hot-spots.
  • Patients with Frameshiftmutation- or Nonsense mutations suffer poor prognosis.
  • Patients with Missense mutations have a better prognosis.
  • In cases with Mutations in the splice-acceptor-region there is no good correlation to determine.
  • Point mutations may have only minor effects.
  • Cases are published in which exactly the same mutation is associated with clearly different outcome.

These results suggest, that probably other factors (Environment, other mutations) will determine the clinical outcome.

Read more at Wikipedia.org


[List your site here Free!]


Concomitant vagal neurofibroma and aplasia of the internal carotid artery in neurofibromatosis type 1 - Brief Article
From Ear, Nose & Throat Journal, 10/1/01 by Muge Ozcan

Abstract

We report the case of a patient with neurofibromatosis type 1 who had both aplasia of an internal carotid artery (ICA) and a vagal neurofibroma. To our knowledge, this is the first report in the literature of the simultaneous presence of these two rare disorders in a single patient. We believe that this is also the first report of an absence of an ICA in a patient with neurofibromatosis type 1. The patient was a 19-year-old woman who complained of a slowly growing neck mass. The mass occupied the right parapharyngeal space and upper cervical region. The patient had no other masses on physical examination, but widespread cafe au lait spots were evident. This led us to suspect the presence of a vagal neurofibroma. The tumor was removed, and pathology confirmed the diagnosis. No intracranial aneurysms were detected on cerebral angiography.

Introduction

Agenesis of the internal carotid artery (ICA) is a rare congenital disorder that was first described by Tode in 1787. [1] Only about 100 cases have been reported to date. The first radiologic demonstration of this anomaly was made by Verbiest during his angiographic study in 1954. [1]

Neurofibroma of the vagus is also rare; when it does occur, it can involve any part of the nerve throughout its cervical course. [2,3] Vagal neurofibromas are usually slow-growing, asymptomatic tumors. They can appear sporadically or in association with neurofibromatosis (von Recklinghausen's disease). [3]

In this article, we describe the case of a patient with neurofibromatosis type 1 who had an absence of an ICA (on the left) and a vagal neurofibroma (on the right). To our knowledge, this is the first report in the literature of these two disorders occurring in the same patient and the first report of an ICA aplasia in a patient with neurofibromatosis type 1.

Case report

A right-handed, 19-year-old woman complained of a mass on the right side of her neck that had been present for 12 months. She was admitted to the hospital. She had no personal history of hoarseness, seizures, or benign neural neoplasms and no family history of neurofibromatosis.

On otolaryngologic examination, her ears, nose, laryngeal structures, and both vocal folds were normal. On oropharyngeal examination, a minimal medial displacement of the right palatine tonsil and soft palate was evident. Findings on transnasal endoscopic examination of the nasopharynx were normal.

Visual inspection revealed that the woman had bilateral axillary freckling and multiple cafe au lait spots larger than 2 cm on her back, abdomen, and both pretibial regions. On palpation, a firm, semimobile, painless, well-circumscribed, nonpulsatile, 4-cm mass was detected medial to the right mandibular angle and upper cervical region deep to the sternocleidomastoid muscle. No other neck mass, lymphadenopathy, or cutaneous neurofibroma was palpable. Results of a neurologic examination were normal except for a minor motor deficit in the right upper extremity.

Computed tomography (CT) of the neck revealed a well-circumscribed, heterogeneous, hypodense, 4.5-cm mass between the jugular foramen and the root of the neck on the right at the level of the oropharynx (figure 1). No cervical lymph nodes were apparent.

During our review of the CT image, we noted that the bony canal for the ICA on the left was hypoplastic. Therefore, we ordered selective angiography of the carotid and vertebral arteries to document the status of both ICAs as well as to ascertain the vascular nature of the mass. Angiography revealed that the left ICA was absent (figure 2). Left anterior and middle cerebral arterial flow was maintained through the anterior communicating artery. The vertebral arteries and the right internal and external carotid arteries were patent and normal. No intracranial aneurysm was present. As for the mass itself, it appeared to displace the right ICA medially, but it was not vascular.

Cranial CT demonstrated a left cerebral hemiatrophy and a secondary enlargement of the left lateral ventricle. Cranial CT confirmed the earlier neck CT finding that the left bony canal for the ICA was hypoplastic (figure 3).

The presence of the cafe au lait spots and the CT appearance of the mass led us to suspect that the patient had a neural tumor, and surgical resection was planned. (CT is mandatory during the preoperative assessment of any parapharyngeal mass. [2]) The mass was surgically removed via a transcervical approach. Intraoperatively, it became evident that the grayish-pink mass had originated in the vagus nerve and had displaced the right ICA medially and the internal jugular vein posteriorly. The mass was bluntly dissected from the major vessels of the neck, but it was not possible to dissect it from the vagus nerve. Therefore, the vagus nerve was severed at the level of the clavicle. The lateral traction of the mandible enabled us to dissect the mass in the parapharyngeal space. The entire mass was excised. No major bleeding occurred. Histopathology confirmed that the mass was a neurofibroma (figure 4).

Postoperatively, the woman experienced tachycardia (which responded well to beta blocker therapy), right vocal fold paralysis, hoarseness, and a minimal degree of dysphagia. Aspiration was not a major problem. She was discharged from the hospital on postoperative day 10 without any complications.

Discussion

ICA anomalies. Congenital ICA anomalies can be classified as agenic, aplastic, or hypoplastic. The absence of the ICA is the result of either agenesis or aplasia. The term a genesis is used when both the ICA and its bony canal are absent; aplasia refers to a situation where the ICA is absent but there is some evidence of a bony canal.[4] Our patient had ICA aplasia, because angiography showed that the ICA was absent while CT showed that a small portion of the bony canal was present. Intracranial aneurysms have been reported in 25% of patients with ICA agenesis. [5] No intracranial aneurysm was detected in our patient.

Patients with ICA anomalies can be asymptomatic. In such cases, the diagnosis can be delayed until a neurologic manifestation appears. When symptoms are present, they are caused by cerebrovascular insufficiency, compression of the brain by vessels that were dilated to compensate for the absence of the ICA, or the presence of an aneurysm. [4] Our patient's chief complaint was the presence of the cervical mass; her complaint had no relation to her ICA aplasia. Aside from the presence of the mass, she was asymptomatic, except for the minimal motor deficit in her right upper extremity.

Vagal neurofibromas. Vagal neurofibromas have been reported sporadically as well as in patients with neurofibromatosis. [3] Our patient had neurofibromatosis type 1. These rare tumors exhibit no predilection toward either sex. [6] Patients are usually asymptomatic, although dysphagia or hoarseness might be evident secondary to Xth cranial nerve paralysis. [2,3,6]

Agenesis of an ICA has been reported in patients with neurofibromatosis type 2, [7] but until now there has been no report of its occurrence in either a patient with neurofibromatosis type 1 or a patient with a vagal neurofibroma.

Because our patient had no ICA on the left, it was important that we preserve the ICA on the right during surgical resection of the mass on the right, and this we were able to accomplish.

The hemicerebral atrophy in our patient was presumed to be related to vascular insufficiency caused by the aplasia of the left ICA. Another case of hemicerebral atrophy with an absence of an ICA has been reported in the literature. [8]

Neurofibromas have been reported to undergo a malignant transformation in approximately 8% of patients with neurofibromatosis. [9] Irradiation has been reported to cause neurofibromas to change into a neurofibrosarcomas in patients with neurofibromatosis. [10]

Surgical resection is the treatment of choice for a vagal neurofibroma. Because it is a benign tumor, the surgeon should attempt to preserve the nerve. This might not be possible when the tumor absorbs nerve axons as it grows. [9]

Acknowledgment

The authors gratefully acknowledge the kind assistance provided by Dr. Murat Ozcan during the preparation of the article.

References

(1.) Worthington C, Olivier A, Melanson D. Internal carotid artery agenesis: Correlation by conventional and digital subtraction angiography, and by computed tomography. Surg Neurol 1984;22:295-300.

(2.) Peetermans JF, Van de Heyning PH, Parizel PM, et al. Neurofibroma of the vagus nerve in the head and neck: A case report. Head Neck 1991;13:56-61.

(3.) Green JD, Jr., Olsen KD, DeSanto LW, Scheithauer BW. Neoplasms of the vagus nerve. Laryngoscope 1988;98:648-54.

(4.) Claros P, Bandos R, Gilea I, et al. Major congenital anomalies of the internal carotid artery: Agenesis, aplasia and hypoplasia. Int J Pediatr Otorhinolaryngol 1999;49:69-76.

(5.) Cali RL, Berg R, Rama K. Bilateral internal carotid artery agenesis: A case study and review of the literature. Surgery 1993;113:227-33.

(6.) Galli J, Almadori G, Paludetti G, et al. Plexiform neurofibroma of the cervical portion of the vagus nerve. J Laryngol Otol 1992;106:643-8.

(7.) Chen MC, Liu HM, Huang KM. Agenesis of internal carotid artery associated with neurofibromatosis type II. AJNR Am J Neuroradiol 1994;15:1184-6.

(8.) Afifi AK, Godersky JC, Menezes A, et al. Cerebral hemiatrophy, hypoplasia of internal carotid artery, and intracranial aneurysm. A rare association occuring in an infant. Arch Neurol 1987;44:232-5.

(9.) Moore G, Yarington CT, Jr., Mangham CA, Jr. Vagal body tumors: Diagnosis and treatment. Laryngoscope 1986;96:533-6.

(10.) Ducatman BS, Scheithauer BW. Postirradiation neurofibrosarcoma. Cancer 1983;51:1028-33.

COPYRIGHT 2001 Medquest Communications, Inc.
COPYRIGHT 2001 Gale Group

Return to Neurofibromatosis type 2
Home Contact Resources Exchange Links ebay